Literature DB >> 20638697

Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection.

Diana Edo-Matas1, Marit J van Gils, Emma J Bowles, Marjon Navis, Andrea Rachinger, Brigitte Boeser-Nunnink, Guillaume B Stewart-Jones, Neeltje A Kootstra, Angélique B van 't Wout, Hanneke Schuitemaker.   

Abstract

The HIV-1 quasispecies in peripheral blood mononuclear cells (PBMC) is considered to be a mix of actively replicating, latent, and archived viruses and may be genetically distinct from HIV-1 variants in plasma that are considered to be recently produced. Here we analyzed the genetic relationship between gp160 env sequences from replication competent clonal HIV-1 variants that were isolated from PBMC and from contemporaneous HIV-1 RNA in serum and HIV-1 proviral DNA in PBMC of four longitudinally studied therapy naïve HIV-1 infected individuals. Replication competent clonal HIV-1 variants, HIV-1 RNA from serum, and HIV-1 proviral DNA from PBMC formed a single virus population at most time points analyzed. However, an under-representation in serum of HIV-1 sequences with predicted CXCR4 usage was sometimes observed implying that the analysis of viral sequences from different sources may provide a more complete assessment of the viral quasispecies in peripheral blood in vivo. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638697     DOI: 10.1016/j.virol.2010.06.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.

Authors:  Zelda Euler; Tom L G M van den Kerkhof; Marit J van Gils; Judith A Burger; Diana Edo-Matas; Pham Phung; Terri Wrin; Hanneke Schuitemaker
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.

Authors:  Lina Josefsson; Martin S King; Barbro Makitalo; Johan Brännström; Wei Shao; Frank Maldarelli; Mary F Kearney; Wei-Shau Hu; Jianbo Chen; Hans Gaines; John W Mellors; Jan Albert; John M Coffin; Sarah E Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

3.  Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.

Authors:  Marit J van Gils; Diana Edo-Matas; Emma J Bowles; Judith A Burger; Guillaume B Stewart-Jones; Hanneke Schuitemaker
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

4.  Elevated hypermutation levels in HIV-1 natural viral suppressors.

Authors:  Lindsay M Eyzaguirre; Manhattan Charurat; Robert R Redfield; William A Blattner; Jean K Carr; Mohammad M Sajadi
Journal:  Virology       Date:  2013-06-19       Impact factor: 3.616

5.  Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.

Authors:  Marit J van Gils; Evelien M Bunnik; Brigitte D Boeser-Nunnink; Judith A Burger; Marijke Terlouw-Klein; Naomi Verwer; Hanneke Schuitemaker
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Disentangling the impact of within-host evolution and transmission dynamics on the tempo of HIV-1 evolution.

Authors:  Bram Vrancken; Guy Baele; Anne-Mieke Vandamme; Kristel van Laethem; Marc A Suchard; Philippe Lemey
Journal:  AIDS       Date:  2015-07-31       Impact factor: 4.177

Review 7.  Clinical significance of HIV-1 coreceptor usage.

Authors:  Hanneke Schuitemaker; Angélique B van 't Wout; Paolo Lusso
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

8.  Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.

Authors:  Evelien M Bunnik; Luke C Swenson; Diana Edo-Matas; Wei Huang; Winnie Dong; Arne Frantzell; Christos J Petropoulos; Eoin Coakley; Hanneke Schuitemaker; P Richard Harrigan; Angélique B van 't Wout
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

9.  Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.

Authors:  Wuze Ren; Alexandra Mumbauer; Ke Zhuang; Carole Harbison; Heather Knight; Susan Westmoreland; Agegnehu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  Retrovirology       Date:  2013-01-31       Impact factor: 4.602

10.  Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.

Authors:  Antoine Chaillon; Martine Braibant; Stéphane Hué; Samia Bencharif; David Enard; Alain Moreau; Assia Samri; Henri Agut; Francis Barin
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.